We Accelerate Access
Our expertise with study recruitment and our mobile fleet's nationwide reach ensures you can rapidly find participants and collect the biospecimens and data you need. With a patient-centric approach, you can have confidence that our staff has the relationships required to facilitate long-term chronic infections research. By streamlining logistics and delivery, we partner with you to speed potentially life-saving therapeutic development.
- Coronavirus Disease 2019 (COVID-19)
- Hepatitis B (HBV)
- Hepatitis C (HCV)
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
Sanguine's Expertise with Infectious Diseases
>4,000
Patient Members
>50
Studies Completed
Contact us to discuss your research needs
Sanguine Services
- Whole Blood
- Serum
- Plasma
- Urine (Lupus Nephritis)
- Skin Taping (Atopic Derm)
- DNA/RNA
- PBMCs (+ Derivatives)
- Hair
- Stool
- Semen
- Nails
- Buffy Coat
- PBMC isolation
- T cell isolation
- B cell isolation
- Natural killer cell isolation
- Chronic hepatitis B
- Disease Confirmation
- Covid-19 (PCR)
- HIV/HPV/Hepatitis/Herpes Etc.
- BioMarker Quantification
- CBC, Platelett, & Diff
- CRP
- Cal-Protecin
- ANA
- Cytokine Panel
- BUN
- Urinalysis
- Thyroid Stimulating Hormone
- Lipid Panel
- LDH
- Genetic Analysis
- HLA Typing
- dsDNA
- RNA Vial Load Qaunitification
- HBV Genotyping
- COVID-19 vaccinated individuals
- COVID-19 convalescent plasma collection
- HIV controller population
The breathtaking pace of research to treat and prevent COVID-19 reveals how quickly the biomedical community can rally to fight infectious disease. Given our access to patients across the country and our mobile collection capacity, Sanguine has been uniquely positioned to support these studies. In addition to COVID-19, for which we supply convalescent serum, our lead areas of expertise include HBV and that other pandemic, HIV. Above all, we seek to create new opportunities for you to advance vital research that improves patients’ wellbeing and protects everyone.
Hear From Our Community
